Vector BioMed’s CEO, Dr. Boro Dropulić, to Speak at the 8th CAR-TCR Summit
- Monday, August 21, 2023, 7:12
- PR Newswire
- Add a comment
Dr. Boro Dropulić to address the need for rapid, high-quality lentiviral vector production to advance CAR-T development GAITHERSBURG, Md., Aug. 21, 2023 /PRNewswire/ — Vector BioMed, a biomanufacturing company specializing in the manufacture of lentiviral vectors, today, announced that…
About the Author
admin has written 20663 stories on this site.